Results 241 to 250 of about 1,651,452 (304)

Ocrelizumab‐induced colitis: VigiBase disproportionality analysis, case reports and literature review

British Journal of Clinical Pharmacology, EarlyView.
Aims Ocrelizumab is a humanized anti‐CD20 monoclonal antibody used in multiple sclerosis. Since its commercialization, several cases of ocrelizumab‐induced colitis have been reported in the scientific literature. Methods To explore the potential association of ocrelizumab with colitis as an adverse drug reaction (ADR), we conducted a descriptive and ...
Audrey Fresse, Christophe Hommel, Nadine Petitpain, Philippe Kerschen   +3 more
wiley   +1 more source

Telomere Dysfunction and Proteostasis Decline Define Distinct Pathways of Cellular Senescence in the Human Respiratory Tract. [PDF]

Aging Cell
Coquette C, Bouchoucha K, Mahieu M, Verleden SE, Loriot A, Norris K, Baird DM, Derumier A, Hoton D, De Sadeleer L, Vanstapel A, Vanaudenaerde BM, Goyet MV, Brichard B, Froidure A, Wuyts W, Van Slambrouck J, Ceulemans LJ, Trigaux W, Huart C, Decottignies A.   +20 more
europepmc   +1 more source

20 years of PediSurv: a critical evaluation of a surveillance network for severe or rare infectious diseases in children in Belgium (2002-2023). [PDF]

Arch Public Health
Peeters I, Dambre C, Dupont Y, Fonnesu M, Hansford K, Cornelissen L.   +5 more
europepmc   +1 more source

Producer responsability and integrated product policy in Belgium [PDF]

, 2004
Lavrysen, Luc, Misonne, Delphine
core  

Association of nasopharyngeal <i>Dolosigranulum pigrum</i> and <i>Corynebacterium</i> species with post-acute sequelae of SARS-CoV-2 in a longitudinal cohort. [PDF]

Microbiol Spectr
Ward B, Bindels LB, Balligand J-L, Bearzatto B, Bommer G, Cani PD, De Greef J, Dewulf JP, Gatto L, Haufroid V, Jodogne S, Kabamba B, Pyr Dit Ruys S, Vertommen D, Yombi JC, Belkhir L, Elens L.   +16 more
europepmc   +1 more source

Information society and criminal justice: report for Belgium [PDF]

, 2013
Vermeulen, Gert, Verrydt, Lynn
core   +1 more source

Leveraging Digital Technology and Artificial Intelligence to Describe the Real-World Belgian Chronic Lymphocytic Leukemia Patient Population: The BE-CLLEAR Study. [PDF]

JCO Clin Cancer Inform
Vanderkerken M, Van Eygen K, Galle V, Verbiest A, Janssens A, Masuy I, Theys K, Cuppens T, Muylle K, De Becker A.   +9 more
europepmc   +1 more source

Footloose Multinationals in Belgium?. [PDF]

Van Beveren, Ilke
core